Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2013

Feb 5, 2013

30016_dirs_2013-02-05_df810c47-586b-4f51-b490-2b8850bdcfe0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2013-02-01

Reporting Person: RAINES MERILEE (Executive VP & CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-02-01 Common Stock M 13581 $34.3700 Acquired 51581 Direct
2013-02-01 Common Stock S 13581 $94.4108 Disposed 38000 Direct
2013-02-01 Common Stock S 31900 $94.7466 Disposed 6100 Direct
2013-02-01 Common Stock S 6100 $95.8640 Disposed 0 Direct
2013-02-01 Common Stock S 29052 $94.7439 Disposed 5948 Indirect
2013-02-01 Common Stock S 5948 $95.8086 Disposed 0 Indirect
2013-02-04 Common Stock M 20440 $41.9350 Acquired 20440 Direct
2013-02-04 Common Stock M 26000 $28.6550 Acquired 46440 Direct
2013-02-04 Common Stock M 24000 $25.4500 Acquired 70440 Direct
2013-02-04 Common Stock M 17736 $56.9500 Acquired 88176 Direct
2013-02-04 Common Stock M 1 $34.3700 Acquired 88177 Direct
2013-02-04 Common Stock M 8120 $53.3100 Acquired 96297 Direct
2013-02-04 Common Stock M 2851 $77.5900 Acquired 99148 Direct
2013-02-04 Common Stock S 84486 $93.6295 Disposed 14662 Direct
2013-02-04 Common Stock S 4862 $94.3454 Disposed 9800 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-02-01 Non-Qualified Stock Option (right to buy) $34.3700 M 13581 Disposed 2016-02-13 Common Stock (13581) Direct
2013-02-04 Incentive Stock Option (right to buy) $41.9350 M 2384 Disposed 2014-02-13 Common Stock (2384) Direct
2013-02-04 Incentive Stock Option (right to buy) $28.6550 M 3488 Disposed 2015-02-02 Common Stock (3488) Direct
2013-02-04 Incentive Stock Option (right to buy) $25.4500 M 3928 Disposed 2014-02-04 Common Stock (3928) Direct
2013-02-04 Non-Qualified Stock Option (right to buy) $28.6550 M 22512 Disposed 2015-02-02 Common Stock (22512) Direct
2013-02-04 Non-Qualified Stock Option (right to buy) $41.9350 M 18056 Disposed 2014-02-13 Commom Stock (18056) Direct
2013-02-04 Non-Qualified Stock Option (right to buy) $56.9500 M 17736 Disposed 2015-02-13 Common Stock (17736) Direct
2013-02-04 Incentive Stock Option (right to buy) $34.3700 M 1 Disposed 2016-02-13 Common Stock (1) Direct
2013-02-04 Non-Qualified Stock Option (right to buy) $53.3100 M 8120 Disposed 2017-02-13 Common Stock (8120) Direct
2013-02-04 Non-Qualified Stock Option (right to buy) $77.5900 M 2851 Disposed 2018-02-13 Common Stock (2851) Direct
2013-02-04 Non-Qualified Stock Option (right to buy) $25.4500 M 20072 Disposed 2014-02-04 Common Stock (20072) Direct

Footnotes

F1: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $94.24 to $94.64, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 2, 3, 4, 5, 6 and 7 to this Form 4.

F2: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $94.22 to $95.21, inclusive.

F3: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $95.22 to $96.18, inclusive.

F4: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $94.24 to $95.23, inclusive.

F5: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $95.24 to $96.19, inclusive.

F6: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $93.26 to $94.20, inclusive.

F7: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $94.28 to $94.46, inclusive.

F8: Grant of options to buy shares of common stock becomes exercisable as to 4,527 shares on 02/14/2010, 02/14/2011 and 02/14/2012, 4,526 shares on 02/14/2013, and the remaining 1,618 shares on 02/14/2014.

F9: Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/14/2012) of the grant.

F10: Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/03/2010) of the grant.

F11: Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/05/2009) of the grant.

F12: Grant of options to buy shares of common stock becomes exercisable as to 5,200 shares on 02/03/2006, 02/03/2007, 02/03/2008, and 02/03/2009, and the remaining 1,712 shares on 02/03/2010.

F13: Grant of options to buy shares of common stock becomes exercisable as to 4,088 shares on 02/14/2008, 02/14/2009, 02/14/2010, and 02/14/2011, and the remaining 1,704 shares on 02/14/2012.

F14: Grant of options to buy shares of common stock becomes exercisable as to 4,434 shares on 02/14/2009, 02/14/2010, 02/14/2011, and 02/14/2012, and the remaining 2,678 shares on 02/14/2013.

F15: Grant of options to buy shares of common stock becomes exercisable as to 1 share on 02/14/2010 and 02/14/2013, and the remaining 2,909 shares on 02/14/2014.

F16: Grant of options to buy shares of common stock becomes exercisable as to 4,060 shares on 02/14/2011, 02/14/2012 and 02/14/2013, 4,059 shares on 02/14/2014, and the remaining 2,184 shares on 02/14/2015.

F17: Grant of options to buy shares of common stock becomes exercisable as to 2,851 shares on 02/14/2012, 02/14/2013, 02/14/2014 and 02/14/2015, and the remaining 1,563 shares on 02/14/2016.

F18: Grant of options to buy shares of common stock becomes exercisable as to 4,800 shares on 02/05/2005, 02/05/2006, 02/05/2007 and 02/05/2008, and the remaining 872 shares on 02/05/2009.